Sahar Awwad, Nkiruka Ibeanu, Tianyang Liu, Angeliki Velentza-Almpani, Nerisha Chouhan, Stavros Vlatakis, Peng Tee Khaw, Steve Brocchini & Yann Bouremel. (2023) Real-Time Monitoring Platform for Ocular Drug Delivery. Pharmaceutics 15:5, pages 1444.
Crossref
Dermot F. McGinnity & Ken Grime. 2023. The Handbook of Medicinal Chemistry. The Handbook of Medicinal Chemistry
298
323
.
Manthena V. S. Varma, Ayman El‐Kattan & Yurong Lai. 2022. Drug Transporters. Drug Transporters
433
452
.
Sahar Awwad, Christin Henein, Nkiruka Ibeanu, Peng T. Khaw & Steve Brocchini. (2020) Preclinical challenges for developing long acting intravitreal medicines. European Journal of Pharmaceutics and Biopharmaceutics 153, pages 130-149.
Crossref
Michael Davies, Rhys D.O. Jones, Ken Grime, Rasmus Jansson-Löfmark, Adrian J. Fretland, Susanne Winiwarter, Paul Morgan & Dermot F. McGinnity. (2020) Improving the Accuracy of Predicted Human Pharmacokinetics: Lessons Learned from the AstraZeneca Drug Pipeline Over Two Decades. Trends in Pharmacological Sciences 41:6, pages 390-408.
Crossref
Rob C. van Wijk, Rami Ayoun Alsoud, Hans Lennernäs & Ulrika S. H. Simonsson. (2020) Model-Informed Drug Discovery and Development Strategy for the Rapid Development of Anti-Tuberculosis Drug Combinations. Applied Sciences 10:7, pages 2376.
Crossref
Philip Gardiner, Rhona J. Cox & Ken Grime. (2019) Plasma Protein Binding as an Optimizable Parameter for Acidic Drugs. Drug Metabolism and Disposition 47:8, pages 865-873.
Crossref
Angélique Stéphanou, Eric Fanchon, Pasquale F. Innominato & Annabelle Ballesta. (2018) Systems Biology, Systems Medicine, Systems Pharmacology: The What and The Why. Acta Biotheoretica 66:4, pages 345-365.
Crossref
Nicole A. Kratochwil, Miriam Triyatni, Martina B. Mueller, Florian Klammers, Brian Leonard, Dan Turley, Josephine Schmaler, Aynur Ekiciler, Birgit Molitor, Isabelle Walter, Pierre-Alexis Gonsard, Charles A. Tournillac, Alexandre Durrwell, Michaela Marschmann, Russell Jones, Mohammed Ullah, Franziska Boess, Giorgio Ottaviani, Yuyan Jin, Neil J. Parrott & Stephen Fowler. (2018) Simultaneous Assessment of Clearance, Metabolism, Induction, and Drug-Drug Interaction Potential Using a Long-Term In Vitro Liver Model for a Novel Hepatitis B Virus Inhibitor. Journal of Pharmacology and Experimental Therapeutics 365:2, pages 237-248.
Crossref
Angela Effinger, Caitriona M. O’Driscoll, Mark McAllister & Nikoletta Fotaki. 2018. ADME Processes in Pharmaceutical Sciences. ADME Processes in Pharmaceutical Sciences
301
330
.
Louis Leung, Xin Yang, Timothy J. Strelevitz, Justin Montgomery, Matthew F. Brown, Michael A. Zientek, Christopher Banfield, Adam M. Gilbert, Atli Thorarensen & Martin E. Dowty. (2017) Clearance Prediction of Targeted Covalent Inhibitors by In Vitro-In Vivo Extrapolation of Hepatic and Extrahepatic Clearance Mechanisms. Drug Metabolism and Disposition 45:1, pages 1-7.
Crossref
D.F. McGinnity & K. Grime. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
34
44
.
Ester Papa, Jon A. Arnot, Alessandro Sangion & Paola Gramatica. 2017. Advances in QSAR Modeling. Advances in QSAR Modeling
425
451
.
M. Schaefer, G. Schanzle, D. Bischoff & R. D. Sussmuth. (2015) Upcyte Human Hepatocytes: a Potent In Vitro Tool for the Prediction of Hepatic Clearance of Metabolically Stable Compounds. Drug Metabolism and Disposition 44:3, pages 435-444.
Crossref
Graham Lappin. (2016) Approaches to intravenous clinical pharmacokinetics: Recent developments with isotopic microtracers. The Journal of Clinical Pharmacology 56:1, pages 11-23.
Crossref
Sahar Awwad, Alastair Lockwood, Steve Brocchini & Peng T. Khaw. (2015) The PK-Eye: A Novel In Vitro Ocular Flow Model for Use in Preclinical Drug Development. Journal of Pharmaceutical Sciences 104:10, pages 3330-3342.
Crossref
Tetsuya Mitsui, Takayuki Nemoto, Taiji Miyake, Shunsuke Nagao, Kotaro Ogawa, Motohiro Kato, Masaki Ishigai & Hideyuki Yamada. (2014) A Useful Model Capable of Predicting the Clearance of Cytochrome P450 3A4 (CYP3A4) Substrates in Humans: Validity of CYP3A4 Transgenic Mice Lacking Their Own Cyp3a Enzymes. Drug Metabolism and Disposition 42:9, pages 1540-1547.
Crossref
Ayman El‐Kattan, Manthena V. Varma & Yurong Lai. 2014. Drug Transporters. Drug Transporters
371
387
.
Franco Lombardo, R. Scott Obach, Manthena V. Varma, Rowan Stringer & Giuliano Berellini. (2014) Clearance Mechanism Assignment and Total Clearance Prediction in Human Based upon in Silico Models. Journal of Medicinal Chemistry 57:10, pages 4397-4405.
Crossref
Aleksandra Galetin. 2014. Enzyme Kinetics in Drug Metabolism. Enzyme Kinetics in Drug Metabolism
255
288
.
David Stepensky. (2013) Prediction of Drug Disposition on the Basis of its Chemical Structure. Clinical Pharmacokinetics 52:6, pages 415-431.
Crossref
Pär Nordell, Petter Svanberg, James Bird & Ken Grime. (2013) Predicting Metabolic Clearance for Drugs That Are Actively Transported into Hepatocytes: Incubational Binding as a Consequence of in Vitro Hepatocyte Concentration Is a Key Factor. Drug Metabolism and Disposition 41:4, pages 836-843.
Crossref
Kenneth H. Grime, Patrick Barton & Dermot F. McGinnity. (2013) Application of In Silico, In Vitro and Preclinical Pharmacokinetic Data for the Effective and Efficient Prediction of Human Pharmacokinetics. Molecular Pharmaceutics 10:4, pages 1191-1206.
Crossref
Franco Lombardo, Nigel J. Waters, Upendra A. Argikar, Michelle K. Dennehy, Jenny Zhan, Mithat Gunduz, Shawn P. Harriman, Giuliano Berellini, Ivana Liric Rajlic & R. Scott Obach. (2013) Comprehensive Assessment of Human Pharmacokinetic Prediction Based on In Vivo Animal Pharmacokinetic Data, Part 2: Clearance. The Journal of Clinical Pharmacology 53:2, pages 178-191.
Crossref
Jian YinHongxia QiuJing DaiYanhua LuRong ZhaoLi ChenQin Meng. (2013) Prediction of hepatic plasma clearance in vivo from gel-entrapped rat and human hepatocytes. Canadian Journal of Physiology and Pharmacology 91:2, pages 178-186.
Crossref
Ken Grime & Stuart W. Paine. (2013) Species Differences in Biliary Clearance and Possible Relevance of Hepatic Uptake and Efflux Transporters Involvement. Drug Metabolism and Disposition 41:2, pages 372-378.
Crossref
Sibylle Neuhoff, Lu Gaohua, Howard Burt, Masoud Jamei, Linzhong Li, Geoffrey T. Tucker & Amin Rostami-Hodjegan. 2013. Transporters in Drug Development. Transporters in Drug Development
155
177
.
Bruce Campbell & Bob Ings. 2013. Global Approach in Safety Testing. Global Approach in Safety Testing
119
158
.
Helena Anna Thörn, Erik Sjögren, Paul Alfred Dickinson & Hans Lennernäs. (2012)
Binding Processes Determine the Stereoselective Intestinal and Hepatic Extraction of Verapamil
in Vivo
. Molecular Pharmaceutics 9:11, pages 3034-3045.
Crossref
Giuliano Berellini, Nigel J. Waters & Franco Lombardo. (2012) In silico Prediction of Total Human Plasma Clearance. Journal of Chemical Information and Modeling 52:8, pages 2069-2078.
Crossref
Manthena V. S. Varma, George Chang, Yurong Lai, Bo Feng, Ayman F. El-Kattan, John Litchfield & Theunis C. Goosen. (2012) Physicochemical Property Space of Hepatobiliary Transport and Computational Models for Predicting Rat Biliary Excretion. Drug Metabolism and Disposition 40:8, pages 1527-1537.
Crossref
Kevin Beaumont, Iain Gardner, Kathryn Chapman, Michael Hall & Malcolm Rowland. (2011) Toward an integrated human clearance prediction strategy that minimizes animal use. Journal of Pharmaceutical Sciences 100:10, pages 4518-4535.
Crossref
James A. McLure, Donald J. Birkett, David J. Elliot, J. Andrew Williams, Andrew Rowland & John O. Miners. (2011) Application of the Fluorescent Probe 1-Anilinonaphthalene-8-Sulfonate to the Measurement of the Nonspecific Binding of Drugs to Human Liver Microsomes. Drug Metabolism and Disposition 39:9, pages 1711-1717.
Crossref
Malcolm RowlandCarl Peck & Geoffrey Tucker. (2011) Physiologically-Based Pharmacokinetics in Drug Development and Regulatory Science. Annual Review of Pharmacology and Toxicology 51:1, pages 45-73.
Crossref
P Zhao, L Zhang, J A Grillo, Q Liu, J M Bullock, Y J Moon, P Song, S S Brar, R Madabushi, T C Wu, B P Booth, N A Rahman, K S Reynolds, E Gil Berglund, L J Lesko & S-M Huang. (2010) Applications of Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation During Regulatory Review. Clinical Pharmacology & Therapeutics 89:2, pages 259-267.
Crossref
Hans V. Westerhoff, Malkhey Verma, Frank J. Bruggeman, Alexey Kolodkin, Maciej Swat, Neil Hayes, Maria Nardelli, Barbara M. Bakker & Jacky L. Snoep. 2011. BetaSys. BetaSys
437
458
.
Michael S. Roberts. (2010) Drug structure–transport relationships. Journal of Pharmacokinetics and Pharmacodynamics 37:6, pages 541-573.
Crossref
Takahide Uchimura, Motohiro Kato, Tomohisa Saito & Haruki Kinoshita. (2010) Prediction of human blood-to-plasma drug concentration ratio. Biopharmaceutics & Drug Disposition, pages n/a-n/a.
Crossref